We are live on ! Find out more
ENTX icon

Entera Bio
ENTX

12 hedge funds and large institutions have $2.17M invested in Entera Bio in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

33% more funds holding

Funds holding: 9 → 12 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.91% less ownership

Funds ownership: 9.83% → 8.92% (-0.91%)

34% less capital invested

Capital invested by funds: $3.28M → $2.17M (-$1.12M)

Holders
12
Holders Change
+3
Holders Change %
+33.33%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
2
Reduced
1
Closed
2
Calls
$36K
Puts
–
Net Calls
+$36K
Net Calls Change
-$8K

Top Buyers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
+$22.6K
2
HighTower Advisors
HighTower Advisors
Illinois
+$10.1K
3
Renaissance Technologies
Renaissance Technologies
New York
+$4.87K
4
Osaic Holdings
Osaic Holdings
Arizona
+$640
5
Morgan Stanley
Morgan Stanley
New York
+$85

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$343K
2
UBS Group
UBS Group
Switzerland
-$7.41K
3
JP Morgan Chase
JP Morgan Chase
New York
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Knoll Capital Management
Florida
$2.09M – – –
HF
2
HRT Financial
New York
$22K +$22.6K +26,414 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$15K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$14K +$4.87K +5,700 +55%
HighTower Advisors
5
HighTower Advisors
Illinois
$10K +$10.1K +11,830 New
PNC Financial Services Group
6
PNC Financial Services Group
Pennsylvania
$8.43K – – –
Morgan Stanley
7
Morgan Stanley
New York
$928 +$85 +100 +10%
UBS Group
8
UBS Group
Switzerland
$897 -$7.41K -8,676 -89%
Osaic Holdings
9
Osaic Holdings
Arizona
$633 +$640 +750 New
Citadel Advisors
10
Citadel Advisors
Florida
$27 +$27 +32 New
RCM
11
RA Capital Management
Massachusetts
– -$343K -295,966 Closed
JP Morgan Chase
12
JP Morgan Chase
New York
– -$2K -1,868 Closed
Simplex Trading
13
Simplex Trading
Illinois
– +$85 +99 New

ENTX Hedge Fund Activity: Q2 2023 in Review

12 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q2 2023, worth a combined $2.17M — down 34% from $3.28M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ENTX positions and 2 closed out — a net gain of 3 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $22.6K. The largest seller was RA Capital Management, exiting entirely with an estimated $343K sold.

  • 12 institutional investors held Entera Bio (ENTX) as of Q2 2023, up from 9 in Q1 2023.
  • Funds reported $2.17M of Entera Bio stock for Q2 2023, down 34% quarter-over-quarter.
  • 5 funds opened new Entera Bio positions in Q2 2023 and 2 closed out, a net change of +3 holders.
  • The largest Entera Bio buyer in Q2 2023 was HRT Financial, an estimated $22.6K added.
  • The largest Entera Bio seller in Q2 2023 was RA Capital Management, an estimated $343K sold.

Based on aggregated 13F filings for Q2 2023.